Cronus Pharma LLC, a fully integrated animal health company, today announced the launch of Florfinasone Otic (florfenicol, terbinafine, mometasone furoate), an FDA-approved product indicated for the treatment of otitis externa in dogs associated with susceptible strains of yeast (Malassezia pachydermatis) and bacteria (Staphylococcus pseudintermedius).

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261001933459/en/

Florfinasone Otic is a fixed-combination therapy that provides antibacterial, antifungal, and anti-inflammatory activity in a convenient single-use formulation. The product contains 16.6 mg/mL florfenicol, 14.8 mg/mL terbinafine (equivalent to 16.6 mg/mL terbinafine hydrochloride), and 2.2 mg/mL mometasone furoate. Proper patient selection is important when veterinarians consider the benefits and risks of using Florfinasone Otic. The integrity of the tympanic membrane should be confirmed before administering the product. Florfinasone Otic is not for use in cats.

"At Cronus Pharma, we are committed to delivering high-quality, cost-effective solutions that improve animal health outcomes and support veterinarians in clinical practice," said Janel Fisher, Vice President of Sales at Cronus Pharma. "The launch of Florfinasone Otic expands our portfolio with an effective treatment option designed to address susceptible bacterial, fungal, and inflammatory components commonly associated with canine otitis externa."

Florfinasone Otic combines three active ingredients with complementary mechanisms of action:

• Florfenicol: A bacteriostatic antibiotic that acts by inhibiting protein synthesis.
• Terbinafine: An antifungal agent that selectively inhibits the early synthesis of ergosterol.
• Mometasone Furoate: A glucocorticosteroid with anti-inflammatory activity.

This product is approved by the U.S. Food and Drug Administration under ANADA #200-848 and is currently available in cartons of ten single-use dropperettes, with each dropperette containing 1mL dose for convenient administration.

Accessible to Veterinarians Nationwide
Cronus Pharma’s Florfinasone OTIC is available through national and regional distributors, making it convenient for veterinarians to access this important medication for canine otitis. Full product information is available from your veterinarian and should be reviewed prior to use. Our focus on quality and accessibility ensures that veterinarians and pet owners can trust our products.

About Cronus Pharma
Based in East Brunswick, New Jersey, Cronus Pharma is a privately held veterinary generic pharmaceutical company dedicated to advancing animal health. With integrated research, development, manufacturing, and marketing, we deliver innovative and cost-effective solutions for animals. Our passionate team of scientists is actively developing new products, with a robust pipeline awaiting FDA approval. Cronus Pharma is committed to supporting veterinarians and pet owners with high-quality, accessible solutions.

Learn more about our mission to enhance animal health at www.cronuspharmausa.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20261001933459/en/